Oragenics
OGEN
10 hedge funds and large institutions have $192K invested in Oragenics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 17 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.1% more ownership
Funds ownership: 0% → 0.1% (+0.1%)
58% less funds holding
Funds holding: 24 → 10 (-14)
82% less capital invested
Capital invested by funds: $1.08M → $192K (-$888K)
82% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$66.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$14K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.33K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$500 |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$167 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$532K |
| 2 |
SBF
Sara-Bay Financial
Sarasota,
Florida
|
-$134K |
| 3 |
State Street
Boston,
Massachusetts
|
-$52.1K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$19.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$15.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Victory Capital Management
San Antonio,
Texas
| – | -$1.35K | -7 | Closed |
|
27
Cerity Partners
New York
| – | -$1.07K | -6 | Closed |
|
|
NDSI
28
Newman Dignan & Sheerar Inc
Providence,
Rhode Island
| – | -$1.1K | -6 | Closed |
|
|
SWA
29
Strategies Wealth Advisors
Grand Rapids,
Michigan
| – | -$1.05K | -6 | Closed |
|
|
SWM
30
Spire Wealth Management
Mclean,
Virginia
| – | -$1K | -4 | Closed |
|
31
Morgan Stanley
New York
| – | -$1 | – | – |
|
OGEN Hedge Fund Activity: Q1 2023 in Review
10 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2023, worth a combined $192K — down 82% from $1.08M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of OGEN and 3 opened new positions — a net loss of 14 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $66.7K. The largest seller was Vanguard Group, exiting entirely with an estimated $532K sold.
- 10 institutional investors held Oragenics (OGEN) as of Q1 2023, down from 24 in Q4 2022.
- Funds reported $192K of Oragenics stock for Q1 2023, down 82% quarter-over-quarter.
- 3 funds opened new Oragenics positions in Q1 2023 and 17 closed out, a net change of -14 holders.
- The largest Oragenics buyer in Q1 2023 was Renaissance Technologies, an estimated $66.7K added.
- The largest Oragenics seller in Q1 2023 was Vanguard Group, an estimated $532K sold.
Based on aggregated 13F filings for Q1 2023.